Twitter Roundup

With so many developments at the intersection of genomics and the law, there are often a variety of interesting stories that, for one reason or another, don’t find their way into a full-length posting on the Genomics Law Report. Here is a recap of what I was Tweeting recently @genomicslawyer:

  • RT @NatureNews: Alzheimer’s blood test ‘most accurate’ so far http://ff.im/-wmFC3 by @ewencallaway
  • More on Novartis/Foundation Medicine collaboration from @pgx_reporter: http://bit.ly/i6HtmE
  • RT @matthewherper: A child was saved by DNA sequencing http://bit.ly/g8XHyC
  • RT @ldtimmerman: 5 things to look for this year in healthcare/life sciences. Op-ed from MDV’s Sue Siegel. http://bit.ly/gNQkm4
  • Promise of confidentiality remains. RT @GenomeWeb_News: FDA’s New Rule on Clinical Trial Consent to Take Effect: http://bit.ly/hr7QVP
  • RT @Sagebio: Indeed: RT @scientificblogs: The Genomics Revolution Will Be Standardized..or it won’t be much http://bit.ly/fZ89A7
  • “The Torrent on Ion Torrent”: http://bit.ly/fLVfzl @matthewherper reviews how the blogosphere views the latest in personal genome sequencing
  • RT @GenCounsNews: Unsolicited fradulent DTC genetic tests intercepted in Australia http://bit.ly/ezBQqq
  • Interesting take on Sharfstein’s FDA departure by @RPMReportMike: http://bit.ly/hLPJDy LDT reg not immune to pol. shift HT @InVivoBlogChris
  • A repackaging of @matthewherper’s story on Rothberg & Ion Torrent (http://bit.ly/hvcZg2) by the NYT (http://nyti.ms/gKb2tu)
  • genetic tests “…are often no more similar than, say, lawnmowers & Formula One race cars that all rely upon the internal combustion engine”
  • Ronald Weiss of @Health_Affairs argues not all genetic tests should be regulated the same way: http://bit.ly/hbGzpm HT @PHGFoundation
  • RT @InSequence: Next-Gen Sequencing Makes Inroads into Clinical Applications in 2010: http://bit.ly/hg8TzZ
  • RT @bmahersciwriter: Polishing up the crystal ball. @naturenews’s breakthrough predictions for 2011. http://bit.ly/hyGBsJ
  • RT @matthewherper: Am I all hype, no substance? http://ow.ly/3xZnd
  • RT @GenomeWeb_News: Foundation Medicine, Novartis Partner on Cancer Diagnostic: http://bit.ly/g6zeR3
  • Profile of Cancer Commons by @ldtimmerman: http://bit.ly/gDQQqA Interesting. Like a cross b/w @Sagebio & @patientslikeme
  • RT @dgmacarthur: Sequencing a human genome to 30X with current $PACB machine would take ~3 years… http://j.mp/h49Aiy (via @SEQanswers)
  • MT @MishaAngrist: That after 85 years the *&%$ Scopes trial is still like Groundhog Day is pathetic. http://bit.ly/fs433L
  • “DTC Poetry Slam”: @Myraqa takes another swipe at @23andMe / DTC: http://bit.ly/hsoYG1 More convincing if an actual haiku (5/7/5)?
  • RT @crossborderbio: Registration for HHS Electronic Health Records Incentive Program has begun. Info and link at http://bit.ly/i3zWtw @ahier
  • What happens if model changes right after you buy? | @23andMe to ‘Experiment’ w/ Different Price Models in 2011: http://bit.ly/i77tMR
  • Next #NYCscitweetup is week of Jan 17th – options here: http://bit.ly/hH6qct thx to @LouWoodley @virginiahughes et al for organizing
  • RT @Globecarolynyj: MGH partners w/ J&J to develop & commercialize blood test to detect tumor cells http://ow.ly/3xrcn
  • RT @GenomeWeb_News: Rosetta Genomics Gets NY State Permit for microRNA Tests: http://bit.ly/eDULJk
  • Med-tech lagging other VC investments due to “more cautious FDA”: http://bit.ly/emW7GG
  • Biolaw holds its coming of age party in SF, 1/5: http://bit.ly/eVFt1S H/T @raymondmccauley
  • Dear Twitter: “I have a friend looking for book recs for his 15 year old in the areas of biology/biochemistry/immunology.” Any suggestions?
  • RT @matthewherper: A first critique of my DNA sequencing story: http://ow.ly/3we8X
  • A short recap of the “anything but robust” IPO & PE environment for “omics-related” companies: http://bit.ly/eA303r
  • Clinical Data Completes Sale of Genetic, PGx Test Business to Transgenomic (@gw_dailyscan): http://bit.ly/i5bgkF
  • RT @FierceBiotech: Burrill predicts big surge in biotech buyouts for 2011. http://bit.ly/fP7mX2
  • “Genome Hackers” by @kashhill: http://bit.ly/gJ3Mhc Disagree w/ exclusive focus on risks but agree federal DNA privacy law a good idea.
  • RT @dgmacarthur: Great Forbes piece by @matthewherper on new DNA sequencing technologies: http://ow.ly/3vUCG
  • RT @ScienceInsider: Scientists Oppose Crime Lab Shutdown: http://bit.ly/gfaNBE
  • Where is my mind-reading phone? RT @sociallifeofdna: “citizen scientists” in IBM’s annual Five in Five innovations list http://bit.ly/hwBmXD
  • RT @jasonbobe: Funded: The Citizen Science Quarterly: http://kck.st/awhSXs (congrats Jacob)
  • RT @Xconomy: XDx, after long slog in molecular diagnostics, predicts 1st profit in 2011. http://bit.ly/eIRDWy
  • “Patently False:” @C_G_S asks whether BIO is trying to spin a study on the public’s attitude toward gene patents: http://bit.ly/fYnHow
  • Nice piece on “the Genome’s Dark Matter” (http://bit.ly/h2v9m0 ) in @techreview
  • RT @dgmacarthur: Great NYT piece by @amy_harmon on researchers using dying cancer patients to refine therapies: http://nyti.ms/g0VPWD
  • GLR Post: MLB Takes Another Swing at Complying with GINA: http://bit.ly/eLUHMa
  • The ‘persons’ and ‘genomics’ of personal genomics by Jenny Reardon: http://bit.ly/hME8u4
  • Hank Greely on risks of personal genomics & other topics (#57 in Discover Mag’s top stories of ’10): http://bit.ly/dESQyG
  • Feature in @techreview mag on “Decade of Genomics”: http://bit.ly/edoHvR incl piece by @emilysinger on cancer genomics: http://bit.ly/eYD62C
  • “Citizen Science Genomics as a Model for Crowdsourced Preventive Medicine Research”: http://bit.ly/ffGbqQ Great stuff from @DIYgenomics
  • RT @matthewherper: The Medical Power of Ritual — what placebo may tell us about doctor-patient relationships. http://bit.ly/dJcoT1
  • Hospital survey: 71% say have inadequate resources to prevent, detect patient data loss: http://bit.ly/hws4yT
  • The NYT is skeptical of China’s promises to improve intellectual property protection: http://nyti.ms/huC3DQ via @BiotechPatent
  • RT @dgmacarthur: RT @edyong209: Nice piece on public understanding of genetics by @lenagroeger http://bit.ly/gGBEV0
  • New post-holiday pricing from @23andMe: $199 + PGS subscription, or buy it w/out PGS sub (but pay $499)
  • HHS (and gov’t more broadly) has lots of work to do in figuring out what it means by patient privacy: http://bit.ly/fZv1I3
  • America COMPETES Act grants broad authority for agencies to use challenge/prize model: http://bit.ly/gBwZnR H/T @genomics_xprize
  • Good, but authorization != appropriation: RT @NatureNews: US Congress passes strategic science bill http://ff.im/-vD8QO
  • RT @BiotechPatent: RT @Xconomy Survey Shows Venture Industry’s Outlook Brightening for 2011 http://xconomy.com/?p=116532
  • $MYGN releases pancreatic cancer test: http://bit.ly/fp8oiB Tests PALB2 & BRCA2 mutations under exclusive license from Hopkins.
  • RT @dgmacarthur: What was your favourite paper of 2010? The @genomesunzipped crew list theirs: http://bit.ly/h2cYTB
  • If @michaelpollan hasn’t read @mary_carmichael’s elegant essay on why genes *do* matter he should. So should you. http://bit.ly/fs3OZE
  • RT @DivaBiotech: Why Life Sciences Companies Must Embrace Social Media Now: http://wp.me/p13MIs-2s
  • (If you have clever suggestions for what to do with (literally) 6-10 dozen out-of-date law review articles on public genomics, pls share.)
  • Today: received 3 boxes of paper copies of my 2008 law review article. Not yet avail: link to article on journal’s website.
  • $GNOM sequenced 300 genomes in Q3; expects to do another 300 in Q4: http://bit.ly/frvksX
  • RT @InSequence: Illumina’s Patent Suit Against Complete Genomics Moves to California, Enters Arbitration Program: http://bit.ly/eNYvUP
  • One more link on BRCA testing: it may work better when combined w/ family history (big surprise): http://bit.ly/ePx6CY
  • Not enough PCPs know when to order BRCA testing: http://bit.ly/gobtRQ by @GW_The_Sample
  • RT @matthewmarkus: $3M prize for the development of an algorithm capable of predicting hospital admissions; http://bit.ly/gSOIlD
  • RT @dgmacarthur: In which @genomesunzipped has some geeky fun playing with the results from our reader survey: http://bit.ly/h64vyE
  • A good first step: RT @noahWG: The US national plan to fight Alzheimer’s Disease: http://j.mp/eQmUio
  • Early Tests for Alzheimer’s Pose Diagnosis Dilemma: http://nyti.ms/dUjn83 My $0.02: not all want to know, but all should have right to know.
  • More on Genspace & the rest of the @DIYBio movement, this time in NYT’s fashion & style section: http://nyti.ms/h0gpkS
  • RT @ewencallaway: Genome prediction contest (@CAGInews) divvies out its first prizes. http://bit.ly/dG91QH
  • RT @genomesunzipped: Friday Links: The rise of the genome bloggers, ion torrent’s release and overcoming genophobia http://bit.ly/fLqqMQ
  • Will Genentech Embrace PGx in Appeal of FDA Decision to Revoke Approval of Avastin in Breast Cancer? http://bit.ly/eN7uBP
  • RT @David_Dobbs: Does Your Genetic Information Long to Be Free? You’re fixin’ to find out | @ Neuron Culture http://bit.ly/fwkx9M
  • Informed consent difficult to achieve in face of “flirty models”? http://nyti.ms/gwNav1
  • “Court Sides with Most of Life Tech’s Proposals for Claim Terms in Illumina Patent Suit”: http://bit.ly/hcjTtp Tough week in court for $ILMN
  • Affy previals (for now) over Illumina in patent infringement suit: http://bit.ly/fKzXKA Don’t worry, plenty of cross-sequencer lit left
  • White House scientific integrity guidelines are out: good principles, short on details: http://bit.ly/gKhSQm (H/T @NatureNews)
  • More on @23andMe’s NIH-funded expansion into consumer-driven genetic research from @pgx_reporter: http://bit.ly/e3j2fm
  • Credit to Pres. Commission for advising self-regulation of synthetic biology: http://nyti.ms/h6qgqG Unsurprisingly, not all are applauding.
  • GLR Post: Prometheus Unbound-Again: http://bit.ly/gvBOVx What today’s ruling means for Myriad & future of biotech patents
  • Prometheus v. Mayo decided: http://bit.ly/far53O Affirmed, holding diagnostic method claims valid. Not really a surprise.
  • RT @dgmacarthur: .@23andMe gets $190K NHGRI grant to validate research platform, find new drug-gene associations: http://bit.ly/iidIdj
  • “Doctors to patients: Track your own health data.” http://bit.ly/eLCP5l A great idea-even though post written by a marketer & quotes 0 MDs
  • Typically stellar work at Genetic Future from @dgmacarthur debunking the BRP attack on genetics: http://bit.ly/hTq78E
  • Overcoming genophobia: “the rhetoric of fear [re: genetic info] does none of us any favors.” http://huff.to/fG01M3 by @MishaAngrist
  • Genome Medicine’s latest issue features Elaine Mardis on “The $1K Genome, The $100K Analysis”: http://bit.ly/dGTubr
  • Wikileaks & the end of secrecy: http://bit.ly/dPp3fJ @Duncande on Pfizer, De-code and surreptitious testing
  • Genspace: A DIY Bio lab opens in NYC, and the FBI approves: http://bit.ly/gOlnSp feat @DanielGrushkin
  • “The Rise of Genome Bloggers”: http://bit.ly/i7MLJi by @ewencallaway & feat @PGorg @genomesunzipped @dienekesp
  • RT @dgmacarthur: Some cold water gets thrown on the @iontorrent PR machine by @pathogenomenick: http://j.mp/gJyCL0
  • More Genoptix sale speculation from @gw_dailyscan. Quest and Sonic the frontrunners? http://bit.ly/gHzvWA
  • More discussion moving to other platforms? MT: @markgfh what’s happening? http://bit.ly/gw3FHM @MishaAngrist @dgmacarthur @mary_carmichael
  • Want to work at NHGRI with @drjonboyg on genomics policy? Job opening here: http://bit.ly/h0gnHg
  • Giving the lab report a makeover (by @Wired): http://bit.ly/gjQRcx Would love to see my own MD employing anything like this
  • Ion Torrent & the search for extraterrestrial life: RT @matthewherper: The DNA Sequencer That Could Go To Mars http://bit.ly/dNeq3C
  • RT @dgmacarthur: Ron Bailey has a spirited defense of genomic libertarianism: http://j.mp/hs2f91 Bravo!
  • Low-cost innovation: RT @dgmacarthur: Crowd-sourcing dev of new sequencing tech-with $1M prizes-is very shrewd: http://bit.ly/Ion3Mprize
  • $GHDX developing 295-gene multiplex prostate cancer recurrence test http://bit.ly/h2FjZP Anybody know the Dx test w/ the most biomarkers?
  • Genoptix is on the auction block: http://bit.ly/dUActP (H/T @GW_The_Sample)
  • GLR Post: A Hint About Where the Federal Circuit Is Going with Method Patents? http://bit.ly/gba0FI #Bilski #Myriad
  • RT @MishaAngrist: “Guess the breeds, win a book.” http://bit.ly/efsUU7 Bkgrnd info here: http://bit.ly/hLT1LS Win a signed 1st ed of #HiaHB!
  • RT @dgmacarthur: RT @GenCounsNews: Canadian government finds regulation of DTC genetic tests unnecessary http://bit.ly/fF0Ucj
  • More @geochurch, part of Harvard team developing microchip-based gene synthesis: http://bit.ly/fzwnGk
  • George Church (@geochurch) interview in @NewScientist on synthetic bio, the PGP/@PGorg & Ozzy: http://bit.ly/dSDYeD
  • Extending statute of limitations after DNA-indictments: http://bit.ly/htVOcE Boston Globe via @DNAlawyer
  • Update on consumer-driven research by @23andMe from @shwu: http://bit.ly/dMGueb
  • From the GLR vault: Hank Greely on the implications of non-invasive prenatal genetic testing: http://bit.ly/1nfDwM
  • RT @ldtimmerman: Genentech’s old antibody shows new life, in combo breast cancer trial w/Herceptin. http://bit.ly/fOEg8Y #SABCS
  • RT @genomesunzipped: It’s Friday Links time again at Genomes Unzipped: unborn genomes, WikiLeaks and Wikipedia science: http://bit.ly/fREaRr
  • Senators call on FDA to “proceed cautiously” with 510(k) changes: http://bit.ly/hlOgeZ
  • MT @nutrigenomics: Excellent frontpage article by @markgfh on “Baby test breakthrough” http://bit.ly/fYHMs0 w/ online Vote Option
  • RT @ldtimmerman: Computing in the age of the $1,000 genome: Xconomy to convene leaders in the field Feb. 7 in Seattle. http://bit.ly/iePBHz
  • RT @GenomeWeb_News: Bayer Schering Pharma, Prometheus Reach Agreement on Oncology Mutational Analyses: http://bit.ly/gjgltS
  • $MYGN acquires melanoma technology from Melanoma Diagnostics: http://bit.ly/fTXUD1 Looks to be another exclusive licensing arrangement.
  • RT @InSequence: Sequencing Reveals Entire Fetal Genome in Maternal Plasma; Opens Door for Noninvasive Prenatal Tests: http://bit.ly/guqwF6
  • RT @FierceBiotech: WikiLeaks spotlights secret catalog of vulnerable vaccine facilities. http://bit.ly/dUtoH1
  • $GNOM emerges from quiet: RT @ldtimmerman: Complete Genomics zeroes in on cancer w/sequencing service. http://bit.ly/gDO8Ex
  • CDC conference on public health & genomics in DC today & tomorrow: http://bit.ly/fWSaPF @mary_carmichael part of a great lineup today
  • “Slut gene”? No. “Slutty science” (& science reporting) that “smack[s] of modern-day phrenology”? Absolutely. http://bit.ly/fi8d66
  • GLR Post: Surreptitious Genetic Testing: WikiLeaks Highlights Gap in Genetic Privacy Law: http://bit.ly/eAncsm
  • RT @JohnCFierce: Enter the bio-dragon. China taps biotech as 1 of 7 industries to grow at 20%+ rate over next 10 yrs. http://reut.rs/dU0fQW
  • RT @genomesunzipped: Kate Morley wonders whether the answer to her family’s high blood iron might lie in their genes http://bit.ly/eVguUf
  • RT @NatureNews: All about patents: Research should be more open, even if that hurts today’s scientists (sub req’d) http://bit.ly/gZNLTI
  • RT @pgx_reporter: PwC Survey Finds Dissatisfaction Among Drug, Device Makers About FDA’s Personalized Rx Efforts: http://bit.ly/gxZlNb
  • RT @GW_The_Sample: As Ref-Lab Send-Outs Climb, More Indie Labs Eye Bigger Esoteric Plays, Survey Finds: http://bit.ly/eZXwLl
  • On TX newborn blood spots, new law allows for opt-out, which is probably reasonable given context #cirge @bigs
  • RT @bigs: TEXAS, even after the brou-haha, is still using assumed consent for research on newborn blood spots. #cirge
  • Provocative post RT @alliejanson: Considering The Future of Genetic Counseling, Act II: http://wp.me/pvgUP-qi
  • “Slut gene”? No. “Slutty science” (& science reporting) that “smack[s] of modern-day phrenology”? Absolutely. http://bit.ly/eWj5un
  • Democratizing DNA Sequencing: http://bit.ly/eWj5un @emilysinger of @techreview previews Ion Torrent’s $50K semiconductor sequencer.
  • RT @MishaAngrist: only the clonely by @EmilyAnthes: http://bit.ly/i296Ok
  • RT @PHGFoundation: Next generation sequencing and non-invasive prenatal diagnosis http://bit.ly/ewQcsH
  • RT @wilbanks: reminded of this by @mrgunn – When and why should you use CC0 for data. 19 big users and counting! http://bit.ly/dUvDS0
  • Nice profile of @GeneSherpas and his personalized medicine practice: http://bit.ly/iaoe1h
  • RT @genomera: RT @bijans: Cool chart: The Apocalyptic Erosion of Biotech P/E Over the Past 10 Years http://twitgoo.com/1rojd3
  • RT @MishaAngrist: “Dear Patient…We apologize for any inconvenience this may cause you.” http://bit.ly/eyuG62 (pdf) #pathetic
  • RT @westr: “New UCLA study raises questions about #genetic testing of newborns http://ow.ly/3lhGF-@InheritedHealth
  • RT @genomera: So you think you can Science? The search for the next Citizen Science Study. http://t.co/C8BqoXx
  • NIH’s Wednesday lecture series features George Church (@geochurch) tomorrow @ 3p: http://bit.ly/gOVjvM (includes webcast) HT @genetics_blog
  • RT @genomesunzipped: Thanks to all who filled out the reader survey: prelim results (+ raw data) now available: http://bit.ly/hu2JOD
  • EPO & Google collaborate on machine translation for pan-European patents: http://bit.ly/eFreGa HT @cheriewoodward
  • RT @virginiahughes: reminder: #NYCscitweetup is on tuesday, here: http://bit.ly/9ON4L2 at 6pm.
  • RT @ldtimmerman: NanoString scoops up breast cancer technology, moves ahead w/diagnostics strategy. http://bit.ly/i84e6g
  • MT @mary_carmichael: Disclosing this info to patients w/out running REVEAL is reckless / @shwu: xkcd on DTC genetics: http://xkcd.com/830/
  • On WikiLeaks story re: alleged Chinese spying on deCODE’s genetic data (http://bit.ly/huVVhG) the obvious question: for what purpose?
  • RT @GW_The_Sample: Behind FDA’s “Vapid,” “Confusing,” “Unhelpful,” and “Ridiculous” LDT-IVD Meeting: http://bit.ly/eWWh0k
  • Re: Genzyme/Fabrazyme: if “imminent FDA approval” needed before NIH marches in, it’ll never happen for a therapeutic
  • NIH declines to exercise march-in rights in Genzyme/Fabrazyme case: http://bit.ly/dYG3gR
  • RT @dgmacarthur: Looking forward to dissecting this piece of idiocy: http://bit.ly/ewrZWK (via @emmecola)
  • Always nice to see @gw_dailyscan pushing public genomics, but the underlying Technorati article adds nothing: http://bit.ly/hItVdK
  • RT @ldtimmerman: Heywood: UK’s NICE is the future–requiring data on real product value. Pharma/biotech needs to start providing it. #cvsf10
  • RT @GenCounsNews: Toronto lab under scrutiny for unreliable prenatal paternity testing http://bit.ly/fkdEz2 (via @cswa_news)
  • RT @crossborderbio: Never too early for biotechs & VCs to understand & plan for payer-focused endpoints http://bit.ly/fDEsbL
  • RT @blaine_5: Dangers of unreliable paternity tests. Articles from @newscientist: http://tinyurl.com/28jbvvd & http://tinyurl.com/29bva9b
  • RT @FurnoX: NIH Considering New Translational Medicine Institute http://ow.ly/3j5U0